换一批Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
第一作者：
S,Cascinu
第一单位：
Department of Medical Oncology, Azienda Ospedaliera di Parma, Italy. cascinu@yahoo.com
作者：
医学主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);置信区间(Confidence Intervals);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);胃肠肿瘤(Gastrointestinal Neoplasms);人类(Humans);输注, 静脉内(Infusions, Intravenous);意大利(Italy);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);预后(Prognosis);喹唑啉类(Quinazolines);危险性评估(Risk Assessment);存活率分析(Survival Analysis);噻吩类(Thiophenes);治疗结果(Treatment Outcome)
DOI
10.1093/annonc/mdf091
PMID
12075739
发布时间
2020-02-03
- 浏览5
Annals of oncology
716-20页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
